Jeff Aronin: Healthcare And Biotech Innovator

Bio

Jeff Aronin has been an innovator in the healthcare and biotech medical field for over twenty years. In Jeff’s career, he has been the successful CEO of many pharmaceutical businesses. Aronin expertise lends to medications and medical sciences involving treatment of rare diseases. Aronin’s expertise lies in his ability to weave business entrepreneurs and medical scientists to provide unchartered therapies and treatments for rare diseases.

 

Jeff Aronin founded Ovation Pharmaceuticals and served as Chief Executive Officer of the pharmaceutical business from its start-up in 2000. Jeff also serves as CEO during the transaction period when Ovation Pharmaceuticals was acquired by Lindbeck, Inc.

 

Paragon Biosciences

 

Jeff Aronin founded Paragon Biosciences on the principle that all medical treatments should be made to patients as soon as possible suffering from rare diseases. Paragon Biosciences is in the business of developing medicines to treat central nervous systems issues, rare hereditary skin disorders, and illness of the immunity system.

 

Paragon Biosciences developed products that are easy to use and have been proven to be effective. Jeff’s company focus on where the patient need has high demand and treatment methods are almost non-existent.

 

Jeff aims to create more in-depth and intensive medical research to center on rare diseases. With Paragon’s extensive research, Jeff’s business can provide the infrastructure that is needed for them to succeed. With the required support in place, medicines can are quickly manufactured for those with rare diseases that have little or no treatment options.

 

Paragon Biosciences have brought many new medicines to the market in the treatment of rare medical illnesses and disorders. In the past ten years alone, Paragon Biosciences has received 13 approvals from the Food and Drug Administration.

 

The Paragon Biosciences has a support system of many companies. Harmony Biosciences, another one of Aronin’s medical ventures, centers its efforts on the identification, development, and regulatory approval of medicines for patients with sleep and central nervous disorders. Castle Creek Pharmaceuticals, another venture portfolio of Aronin’s deals in therapy for patients suffering from rare skin disorders.

 

Currently, over 6000 rare diseases have no known treatment, therapies, cures, or medicines for these rare diseases. Jeff Aronin remains dedicated to the cause of finding medications, remedies, and treatment for these rare diseases.